Compare GOCO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOCO | MYO |
|---|---|---|
| Founded | 2001 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 36.9M |
| IPO Year | 2020 | 2017 |
| Metric | GOCO | MYO |
|---|---|---|
| Price | $1.76 | $0.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.00 | ★ $7.67 |
| AVG Volume (30 Days) | 37.9K | ★ 504.8K |
| Earning Date | 02-26-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $738,338,000.00 | $41,643,203.00 |
| Revenue This Year | N/A | $24.07 |
| Revenue Next Year | N/A | $17.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.56 | ★ 65.00 |
| 52 Week Low | $1.83 | $0.71 |
| 52 Week High | $21.00 | $6.39 |
| Indicator | GOCO | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 32.47 | 37.31 |
| Support Level | $1.83 | $0.76 |
| Resistance Level | $2.10 | $0.85 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 1.35 | 14.97 |
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).